Published in J Anal Toxicol on October 01, 1996
Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem (2008) 0.90
Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther Drug Monit (2011) 0.89
Recent developments in sweat analysis and its applications. Int J Anal Chem (2015) 0.87
Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.85
Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry. Forensic Sci Int (2009) 0.85
Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal Bioanal Chem (2009) 0.81
Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.80
Monitoring pregnant women's illicit opiate and cocaine use with sweat testing. Ther Drug Monit (2010) 0.79
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. J Subst Abuse Treat (2007) 0.79
Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem (2010) 0.78
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Ther Drug Monit (2010) 0.78
Quantification of a methadone metabolite (EDDP) in urine: assessment of compliance. Clin Med Res (2009) 0.77
Analysis of Urine, Oral fluid and Fingerprints by Liquid Extraction Surface Analysis Coupled to High Resolution MS and MS/MS - Opportunities for Forensic and Biomedical Science. Anal Methods (2016) 0.75
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59
Innovative method for carbon dioxide determination in human postmortem cardiac gas samples using headspace-gas chromatography-mass spectrometry and stable labeled isotope as internal standard. Anal Chim Acta (2013) 2.06
A revised model of platelet aggregation. J Clin Invest (2000) 1.54
2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market. J Anal Toxicol (1998) 1.52
Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesth (1988) 1.49
Opiate concentrations in human head, axillary, and pubic hair. J Forensic Sci (1993) 1.45
[Pure laparoscopic versus robotic-assisted laparoscopic radical prostatectomy: comparative study to assess functional urinary outcomes]. Prog Urol (2009) 1.44
Haematological analysis conducted at the departure of the Tour de France 2001. Int J Sports Med (2005) 1.41
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. Cancer Res (1993) 1.41
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. J Thromb Haemost (2005) 1.40
Gas chromatographic analysis of nicotine and cotinine in hair. J Chromatogr (1992) 1.14
Forensic evaluation of the QIAshredder/QIAamp DNA extraction procedure. Forensic Sci Int (2005) 1.10
Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland. Forensic Sci Int (2000) 1.10
Human growth hormone doping in sport. Br J Sports Med (2006) 1.03
Cannabis and sport. Br J Sports Med (2006) 1.00
Mitochondrial DNA polymorphisms: a study of 50 French Caucasian individuals and application to forensic casework. Int J Legal Med (1998) 0.99
Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr (1997) 0.97
[Hemangioma of the pancreas]. J Radiol (1985) 0.96
Central nervous system stimulants and sport practice. Br J Sports Med (2006) 0.95
Fly larvae: a new toxicological method of investigation in forensic medicine. J Forensic Sci (1990) 0.95
DNA fingerprinting from tissues after variable postmortem periods. J Forensic Sci (1993) 0.95
Six deaths linked to misuse of buprenorphine-benzodiazepine combinations. Am J Psychiatry (1998) 0.95
Advances in post-mortem CT-angiography. Br J Radiol (2014) 0.94
Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood (2001) 0.94
The future of glycoprotein VI as an antithrombotic target. J Thromb Haemost (2012) 0.94
Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer (2000) 0.94
Forensic identification of urine samples: a comparison between nuclear and mitochondrial DNA markers. Int J Legal Med (2005) 0.93
Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von willebrand factor interaction. Blood (2000) 0.93
Breathing during sleep in normal young and elderly subjects: hypopneas, apneas, and correlated factors. Sleep (1983) 0.93
Detection of hemorrhage source: the diagnostic value of post-mortem CT-angiography. Forensic Sci Int (2012) 0.93
Multi-phase postmortem CT angiography: recognizing technique-related artefacts and pitfalls. Int J Legal Med (2013) 0.92
Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet (1999) 0.92
Forensic evaluation of mtDNA in a population from south west Switzerland. Int J Legal Med (2000) 0.92
Sweat testing for heroin and metabolites in a heroin maintenance program. Clin Chem (1997) 0.90
(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet (1999) 0.90
Enantioselective analysis of methadone in sweat as monitored by liquid chromatography/ion spray-mass spectrometry. Ther Drug Monit (1998) 0.89
Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J Anal Toxicol (2000) 0.89
Drug testing in addicts: a comparison between urine, sweat, and hair. Ther Drug Monit (1996) 0.89
Analysis of Drugs in Saliva. Forensic Sci Rev (1999) 0.88
Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci Int (2001) 0.88
Apnea following hyperventilation in man. J Neurol Sci (1983) 0.88
[Respiratory changes during sleep in healthy elderly subjects (author's transl)]. Rev Electroencephalogr Neurophysiol Clin (1981) 0.88
Exit association-mediated suicide: toxicologic and forensic aspects. Am J Forensic Med Pathol (1999) 0.88
HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J Forensic Sci (1997) 0.88
Fatal overdose of tramadol and alprazolam. Forensic Sci Int (1999) 0.87
[Evaluation of spiral computed tomography in the demonstration of kidney stones. Ex vivo study]. Prog Urol (1998) 0.87
Testing human hair for cannabis. Forensic Sci Int (1995) 0.86
Testosterone and doping control. Br J Sports Med (2006) 0.86
Fatal flecainide intoxication. Forensic Sci Int (1999) 0.86
Development and validation of a postmortem radiological alteration index: the RA-Index. Int J Legal Med (2012) 0.86
Fatal blunt pancreatic trauma secondary to assault and battery: a case report. Int J Legal Med (2001) 0.86
Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence. Ann Hum Genet (2003) 0.85
Detection of drugs in human hair for clinical and forensic applications. Int J Legal Med (1992) 0.85
Fly larvae and their relevance in forensic toxicology. Am J Forensic Med Pathol (1990) 0.85
Evidence of crack use by anhydroecgonine methylester identification. Hum Exp Toxicol (1997) 0.85
Method for confirmation of synthetic corticosteroids in doping urine samples by liquid chromatography-electrospray ionisation mass spectrometry. J Chromatogr A (2001) 0.85
Detection of drugs in human hair using Abbott ADx, with confirmation by gas chromatography/mass spectrometry (GC/MS). J Forensic Sci (1992) 0.85
Simultaneous determination of opiates, cocaine and major metabolites of cocaine in human hair by gas chromotography/mass spectrometry (GC/MS). Forensic Sci Int (1995) 0.85
Sudden death: ethical and legal problems of post-mortem forensic genetic testing for hereditary cardiac diseases. Clin Genet (2009) 0.85
Erythropoietin and blood doping. Br J Sports Med (2006) 0.85
Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate (2000) 0.85
Fistulous communication of a pancreatic pseudocyst with the common bile duct: demonstration by operative cholangiogram. Am J Gastroenterol (1989) 0.85
Medico-legal investigations of the Airbus, A320 crash upon Mount Ste-Odile, France. J Forensic Sci (1994) 0.84
Evaluation of nicotine and cotinine in human hair. J Forensic Sci (1992) 0.84
Research of stimulants and anabolic steroids in dietary supplements. Scand J Med Sci Sports (2006) 0.84
Effects of midazolam on sleep in normal subjects. Br J Clin Pharmacol (1983) 0.84
Testing human hair for cannabis. II. Identification of THC-COOH by GC-MS-NCI as a unique proof. J Forensic Sci (1995) 0.84
PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Eur J Hum Genet (2001) 0.84
[Prostate cancer. Epidemiology. Risk factors. Pathology]. Ann Urol (Paris) (2004) 0.83
Nonfatal prolonged overdosage of pyrimethamine in an infant: measurement of plasma and urine levels using HPLC with diode-array detection. J Anal Toxicol (1993) 0.83
Toxicological findings in a death involving dextromethorphan and terfenadine. Am J Forensic Med Pathol (1992) 0.83
[Sleep apnea synrome : effects of chlorimipramine in subjects with stable body weight (author's transl)]. Rev Electroencephalogr Neurophysiol Clin (1980) 0.83
Three-dimensional CT-scan reconstruction of renal calculi. A new tool for mapping-out staghorn calculi and follow-up of radiolucent stones. Eur Urol (1997) 0.82
What constitutes a positive result in hair analysis: proposal for the establishment of cut-off values. Forensic Sci Int (1995) 0.82
Oestrogen secreting Leydig cell tumour and GnRH agonist in-vivo and in-vitro studies. Clin Endocrinol (Oxf) (1992) 0.82
Forensic significance of postmortem estimation of the blood cerebrospinal fluid barrier permeability. Forensic Sci Int (1984) 0.82
[Prostate cancer: Diagnosis and staging]. Ann Urol (Paris) (2004) 0.81
[Which is the best performing imaging method for demonstrating residual renal calculi?]. Prog Urol (1998) 0.81
[Tubulo-papillary tumors of the kidney. Clinical, histologic and cytogenetic aspects. 15 new cases]. Prog Urol (1994) 0.81
Detection of nandrolone metabolites in urine after a football game in professional and amateur players: a Bayesian comparison. Forensic Sci Int (2001) 0.81
Pharmacological criteria that can affect the detection of doping agents in hair. Forensic Sci Int (2000) 0.81
[Metastasis of renal adenocarcinoma to the spermatic cord and the epididymis: 2 cases]. Prog Urol (1995) 0.81
Windows of detection of zolpidem in urine and hair: application to two drug facilitated sexual assaults. Forensic Sci Int (2004) 0.80
Application of a simple enzymatic digestion method for diatom detection in the diagnosis of drowning in putrified corpses by diatom analysis. Int J Legal Med (1994) 0.80
Detection of codeine and phenobarbital in sweat collected with a sweat patch. J Anal Toxicol (1996) 0.80
Biogenic amine metabolism in sleep apnea syndrome. Adv Biosci (1979) 0.80
Colchicine poisoning: report of a fatal case and presentation of an HPLC procedure for body fluid and tissue analyses. J Anal Toxicol (1997) 0.80
Hereditary prostate cancer and other genetic predispositions to prostate cancer. Urol Int (1998) 0.80
GPV is a marker of in vivo platelet activation--study in a rat thrombosis model. Thromb Haemost (2000) 0.80